(Image source from: Canva.com)
Cancer is nothing more than untreated growth of abnormal cells. This can affect all organs. This growth is the result of the mutation in the genes that are involved in cell growth and/or repair of DNA. The mutations in life are sporadic mutations and are only referred to as tumor cells. Some types are inherited by parents who lead to increased sensitivity to specific cancer. Such cancer is called "genetic cancer". These types are found in parental cell cells and diagnosed in all personal cells. Dr. Grandma Dong, medical tumor consultant, Fortis Mulund Hospital, the Fortis Hiranandani Hospital, all vashis you need to know.
Various tests were carried out to demonstrate genetic anomalies in cancer cells. This not only contributes to the biology of cancer, but also leads to the development of new medicines in order to target these mutations. It has been shown that the treatment based on the purpose of these mutations improves the reaction and the result of the cancer caused by them and forms the basics of a precise tumor. In addition, genetic tests with people with a strong family history are exposed to cancer risk. You can provide preventive measures for the early diagnosis of cancer and preventive measures for more powerful screening. For example, preventive breast removal or removal of the ovaries by the BRCA -positive patient.
The examination of such a mutation is complex, and the nucleic acid oxibo is exposed to a subsequent reinforcement and reading core acid (RNA) in order to demonstrate abnormalities. This requires special skills and expertise and can only be carried out in a research institute with an appropriate infrastructure. Due to the complexity of the test, the results can take 2-3 weeks or more. The experiment can be decomposed in particular in older tissues if the DNA quality is low.
If a mutation is determined, such patients may be treated depending on the availability of medical products. Patients can also take into account medical examinations that read new drugs compared to these mutations. Often mutations cannot be identified and such patients do not recommend targeted treatment. The advantage of this is that it is a random coincidence that is a special treatment based on the type of cancer. The goal is to "treat the right patient with the right treatment at the right time". Currently, it is primarily advanced malignant patients and is used for those who have only more treatment, such as: B. Rare cancer. Bioplibenwenwen is important for recognizing a lot of and new progress allows new progress to recognize the same contraindications in the blood to avoid biopsy.
Studies in accurate cancer are in progress and new drugs have been made in this area. Nevertheless, treatment with drugs is aimed at new mutations that lead to resistance to tumors. And the recurrent biopsy and progress of the disease may require tests. This is a great promise to revolutionize future cancer and provide more targeted and efficient treatment methods. Progress in this area can significantly improve the survival and quality of life of patients.
